Types of studies may include innovative methods or approaches such as qualitative, mixed methods, observational, quasi-experimental, and experimental with focus on individual- and family-centered outcomes. It is strongly encouraged that the investigative teams be interdisciplinary and include nurse scientists and early stage investigators. Investigators are also encouraged to consider using existing palliative care research networks, such as the Palliative Care Research Cooperative Group, to carry out small, multi-site trials when appropriate.
For more information, visit:
The Cambia Health Foundation recently expanded the Sojourns Scholar Leadership Program to include emerging leaders in palliative care who are physicians, nurses, social workers, physician assistants, chaplains, psychologists, pharmacists and other health system professionals.
The goal is to be a catalyst for system and culture change by developing palliative care leaders who put patients and families first so that they can live well in the face of serious illness. We recognize that passionate leaders who can move the field forward come from diverse backgrounds and multiple disciplines. The Cambia Health Foundation is investing in emerging leaders to improve the quality of life for people with serious illness and to increase the capacity of the field to provide palliative care across multiple settings so that patients and families can access it wherever they want when they need it most.
Interested parties must submit a Letter of Intent by February 1, 2018. After review, a select group of applicants will be invited to submit full applications by June 1, 2018. More information, including details about eligibility, is available at Sojourns Scholar Leadership Program.
Global Palliative Care Quality Alliance is pleased to announce that the 3rd Annual Quality Matters Conference for palliative care and hospice professionals will take place on October 26th, 2017 from 12-5pm EST. Complimentary CME/CNE credits are possible.
Registration is free and the conference is recorded so individuals/teams can watch parts of the conference, and come back and watch the recording later.
For more Information & Registration: http://www.gpcqa.org/qmc
In September, the National Institute of Nursing Research (NINR) will hold the third Director’s Lecture of 2017. Dr. Mary Beth Happ will present: “Giving Voice to the Voiceless: Improving Communication with Critically Ill Patients”
September 20, 2017 1:30 p.m. – 2:30 p.m.
Lipsett Amphitheater (Building 10)
NIH Campus – Bethesda, MD
In her presentation, “Giving Voice to the Voiceless: Improving Communication with Critically Ill Patients,” Dr. Happ will describe her program of research which addresses family bedside presence during critical illness, end-of-life care and treatment decision making in the ICU, and patient and family outcomes in acute-critical illness.
Click to register and add this event to your calendar: https://www.eventbrite.com/e/giving-voice-to-the-voiceless-improving-communication-with-critically-ill-patients-tickets-34893563588?aff=grantees
About the Speaker:
Dr. Mary Beth Happ is a Nursing Distinguished Professor of Critical Care Research and Associate Dean of Research and Innovation at The Ohio State University College of Nursing. She is an NIH-funded researcher in the areas of critical care and aging. For over 20 years, Dr. Happ’s research has focused on improving care and communication with impaired patients, and their families and clinicians during hospitalization and at the end of life. She developed the SPEACS-2 online training program and toolkit for use with ICU patients. She is a fellow in the Gerontological Society of America and the American Academy of Nursing. Dr. Happ has authored more than 120 journal articles, editorials, and book chapters.
About the Event:
This event is free and open to the public. This event will not be webcast, but it will be available on YouTube a few weeks following the lecture.
To request reasonable accommodations, including sign language interpretation, please contact Nathan Brown at 301-594-9262 / [email protected] or the Federal Relay at 1-800-877-8339 before September 13, 2017.
Message to NIH grant applicants/awardees, contractors, researchers and research administrators:
If you are conducting NIH-funded research that involves human subjects, or are considering applying to NIH for support of such research, we want to call your attention to important changes that may affect how you:
- select the right NIH funding opportunity announcement
- write the research strategy and human subjects sections of your application
- comply with appropriate policies and regulations
First, familiarize yourself with the new PHS Human Subject and Clinical Trial Information form (for application due dates of January 25, 2018). Learn about the new form here.
Second, review the updated NIH definition of a clinical trial. Visit the NIH webpage on the definition that includes case studies, FAQs and other resources that can help. Still unsure? Contact your NIH program official or the scientific point of contact listed on the funding opportunity announcement to which you are applying.
Third, familiarize yourself with NIH policy changes related to enhancing stewardship of clinical trials.
Visit the new Clinical Trial Requirements for NIH Grantees and Contractors web page to bring together all the information you need to know. Please review this information carefully. Your attention to detail will be critical to ensuring successful funding of your clinical trial awards.
Be sure to look into the new funding opportunity from the Patient-Centered Outcomes Research Institute (PCORI), entitled, “Symptom Management for Patients with Advanced Illness”. This announcement can be found on the PCORI website.
Email [email protected] with any questions related to this funding announcement.